The Discounted Cash Flow (DCF) valuation of FUREN Group Pharmaceutical Co Ltd (600781.SS) is (138.96) CNY. With the latest stock price at 0.77 CNY, the upside of FUREN Group Pharmaceutical Co Ltd based on DCF is -18147.3%.
Based on the latest price of 0.77 CNY and our DCF valuation, FUREN Group Pharmaceutical Co Ltd (600781.SS) is a sell. selling 600781.SS stocks now will result in a potential gain of 18147.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.1% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (567.24) - (84.71) | (138.96) |
| Upside | -73768.0% - -11101.8% | -18147.3% |